#retatrutide

[ follow ]
#weight-loss-drugs #triple-receptor-agonist #off-label-use #illegal-weight-loss-drugs #trustpilot-reviews
Medicine
fromWIRED
1 day ago

People Are Already Taking This Unapproved New Weight-Loss Drug

Retatrutide, a potent triple-receptor weight-loss injectable from Eli Lilly, is being used unofficially and shows much stronger effects than current approved drugs.
fromwww.theguardian.com
1 week ago

Illegal weight-loss drugs being sold in UK by firms with high Trustpilot scores

Retatrutide, which has not yet completed clinical trials, is an experimental injection developed by the US drugmaker Eli Lilly that targets three gut hormones: GLP-1, GIP and glucagon. Early studies suggest it could help patients lose up to a quarter of their body weight, leading to it being hailed online as the next Ozempic. Ozempic is not licensed in the UK as a weight-loss drug. Buying Retatrutide illegally, however, carries serious risks.
Public health
Public health
fromwww.dw.com
3 weeks ago

Fake Ozempic, Zepbound: Booming despite serious health risks DW 11/18/2025

Counterfeit weight-loss injectables are increasing globally as demand outstrips supply, fueled by celebrity and social media promotion and shortages of legitimate drugs.
Public health
fromwww.independent.co.uk
1 month ago

Warning after King Kong' of weight-loss jabs found being sold on social media

Fake versions of Retatrutide and other weight-loss injections are being sold illegally on social media with false source claims and inconsistent usage instructions.
Public health
fromMedpagetoday
1 month ago

Demand for Unapproved Weight-Loss Drug Surges on Social Media

Unapproved compounded retatrutide is being sold online and promoted by influencers, prompting FDA warnings for illegal marketing and unsafe, misbranded products.
Alternative medicine
fromNatural Health News
3 months ago

A "Hack" For Making Ultraprocessed Foods Less Unhealthy, Eating "Wild Foods," What Sports Make You Smarter (And Increase Longevity) & More: Solosode #493

Microdosing Retatrutide (≈0.25 mg/week) suppresses appetite via GLP-1, GIP, and glucagon pathways and is obtained through physician-screened peptide providers.
Medicine
fromBusiness Insider
3 months ago

Eli Lilly is close to launching the strongest weight-loss drug ever. Somehow, gym bros are already taking it to shred fat.

Retatrutide, a triple-agonist drug by Eli Lilly, promises dramatic weight loss and muscle preservation but remains in clinical trials until at least 2026–2027.
[ Load more ]